88 related articles for article (PubMed ID: 2439425)
21. What can the European Multicenter Trial on the treatment of Graves' disease with antithyroid drugs teach us about the course of thyroid-associated orbitopathy (TAO)? European Multicenter Trial Group.
Benker G; Kahaly GJ; Reinwein D
Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 5():S186-9. PubMed ID: 10614919
[No Abstract] [Full Text] [Related]
22. [Method of medical treatment for Graves' disease based on evidence based medicine].
Nakamura H
Nihon Rinsho; 2006 Dec; 64(12):2243-9. PubMed ID: 17154086
[TBL] [Abstract][Full Text] [Related]
23. [Principles of the medication for Graves' disease and countermeasures against adverse events induced by anti-thyroid drugs].
Nakamura H
Nihon Rinsho; 2012 Nov; 70(11):1915-21. PubMed ID: 23214061
[TBL] [Abstract][Full Text] [Related]
24. Medical aspects on surgery in Graves' disease. Clinical review.
Karlsson FA; Winsa B; Rastad J; Johansson H
Acta Chir Scand; 1990 Jan; 156(1):47-51. PubMed ID: 1690941
[No Abstract] [Full Text] [Related]
25. Strategy for antithyroid drug therapy in Graves' disease.
Allannic H
Horm Res; 1987; 26(1-4):146-53. PubMed ID: 2439428
[TBL] [Abstract][Full Text] [Related]
26. [Cost-utility analysis of antithyroid drug therapy versus 131I therapy for Graves' disease].
Hayashi K; Abe K; Sakata I; Sakaguchi C; Yamamoto K; Kosuda S
Kaku Igaku; 2005 May; 42(2):87-95. PubMed ID: 16038427
[TBL] [Abstract][Full Text] [Related]
27. The longer the antithyroid drug is used, the lower the relapse rate in Graves' disease: a retrospective multicenter cohort study in Korea.
Park SY; Kim BH; Kim M; Hong AR; Park J; Park H; Choi MS; Kim TH; Kim SW; Kang HC; Chung JH
Endocrine; 2021 Oct; 74(1):120-127. PubMed ID: 33860431
[TBL] [Abstract][Full Text] [Related]
28. Graves' disease: developments in first-line antithyroid drugs in the young.
Lane LC; Cheetham T
Expert Rev Endocrinol Metab; 2020 Mar; 15(2):59-69. PubMed ID: 32133893
[No Abstract] [Full Text] [Related]
29. Antithyroid drugs. Practical conclusions.
Leclère J
Horm Res; 1987; 26(1-4):154-7. PubMed ID: 2439429
[TBL] [Abstract][Full Text] [Related]
30. [Basedow's disease: surgery, the choice treatment].
Chiampo L
Minerva Endocrinol; 1987; 12(1):49-53. PubMed ID: 2438548
[No Abstract] [Full Text] [Related]
31. Antithyroid drugs for the treatment of hyperthyroidism caused by Graves' disease.
Cooper DS
Endocrinol Metab Clin North Am; 1998 Mar; 27(1):225-47. PubMed ID: 9534038
[TBL] [Abstract][Full Text] [Related]
32. [Synthetic antithyroid drugs and Basedow's disease or the choice of a therapeutic strategy].
Allannic H; Lorcy Y; Leguerrier AM; Delambre C; Stetieh H; Madec AM; Orgiazzi J
Presse Med; 1991 Apr; 20(14):645-6, 649-51. PubMed ID: 1710802
[TBL] [Abstract][Full Text] [Related]
33. Long-Term Antithyroid Drug Treatment: A Systematic Review and Meta-Analysis.
Azizi F; Malboosbaf R
Thyroid; 2017 Oct; 27(10):1223-1231. PubMed ID: 28699478
[TBL] [Abstract][Full Text] [Related]
34. [Proceedings: Effect of the volume of iodine uptake on recurrence of Basedow's disease: in patients with suppression of iodine uptake due to actions of antithyroid agents].
Nagataki S; Uchimura H; Ikeda H; Matsuzaki F; Imai Y
Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):409. PubMed ID: 4141671
[No Abstract] [Full Text] [Related]
35. Ophthalmopathy of Graves' disease. Outcome after treatment with radioactive iodine, surgery, or antithyroid drugs.
Barbosa J; Wong E; Doe RP
Arch Intern Med; 1972 Jul; 130(1):111-3. PubMed ID: 4113850
[No Abstract] [Full Text] [Related]
36. What is the evidence behind the evidence-base? The premature death of block-replace antithyroid drug regimens for Graves' disease.
Razvi S; Vaidya B; Perros P; Pearce SH
Eur J Endocrinol; 2006 Jun; 154(6):783-6. PubMed ID: 16728536
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of Basedow disease with synthetic antithyroid drugs. Evaluation of the effect of the duration of medical treatment on its long term efficacy].
Allannic H
Ann Endocrinol (Paris); 1994; 55(1):7-10. PubMed ID: 7528488
[TBL] [Abstract][Full Text] [Related]
38. Pathogenic and clinical aspects of Graves' disease.
Feldt-Rasmussen U; Rasmussen AK; Zimmermann-Belsing T; Hartoft-Nielsen ML
Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 3():S71-4. PubMed ID: 10522809
[No Abstract] [Full Text] [Related]
39. [Developmental analysis of 165 cases of Basedow's disease treated with low doses of I-131 associated with synthetic antithyroid drugs in long-term treatment].
Jaffiol C; Baldet L; Ghachem M; Mirouze J
Ann Endocrinol (Paris); 1972; 33(2):148-50. PubMed ID: 4118100
[No Abstract] [Full Text] [Related]
40. [Synthetic antithyroid drugs].
Taurand S
Soins; 1990 Nov; (542):I-II. PubMed ID: 1708918
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
